GET yields 4.26% · MRK yields 2.81%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, GET + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GET + MRK for your $10,000?
Getnet Adquirência e Serviços Para Meios de Pagamento S.A. operates in the acquiring and services market for means of payment regulated by the Council National Monetary Council and the Central Bank of Brazil. The company engages in the provision of accreditation services for retailer and service providers establishments to accept credit and debit cards; capturing, transmission, and processing of data and information; and installation, uninstallation, monitoring, supply, maintenance, and leasing of equipment used in transaction capture networks, such as point-of-sales devices, as well as acts as a distributor of telecommunication operators for the commercialization of telephony and data recharge digital credits. It is also involved in the management of payments and receipts made to establishments accredited to its network; development and selling or licensing of software; selling or distributing products and services from entities that provide registry information; provision of technical, commercial, and logistic infrastructure services for the business related to the receipt of bills from dealers, banks, and other collection documents; and issuing electronic currency. The company was formerly known as Farthi Empreendimentos e Participações S.A. and changed its name to Getnet Adquirência e Serviços para Meios de Pagamento S.A. in August 2014. The company was founded in 2003 and is headquartered in São Paulo, Brazil. Getnet Adquirência e Serviços para Meios de Pagamento S.A. is a subsidiary of PagoNxt Merchant Solutions, S.L.
Full GET Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.